Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	Affected	At risk
Total, all-cause mortality	LIK066 30 mg	0	43
Total, all-cause mortality	LIK066 150 mg	0	43
Total, all-cause mortality	Placebo	0	21
Total, all-cause mortality	All Patients	0	107
Total, other adverse events	LIK066 30 mg	31	43
Total, other adverse events	LIK066 150 mg	36	43
Total, other adverse events	Placebo	18	21
Total, other adverse events	All Patients	85	107
Total, serious adverse events	LIK066 30 mg	0	43
Total, serious adverse events	LIK066 150 mg	0	43
Total, serious adverse events	Placebo	1	21
Total, serious adverse events	All Patients	1	107

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03205150/event-totals